MedPath

OXALITIN

Brand Name: OXALITIN

Generic Name: OXALIPLATIN

Active
Registration Number

DR-XY46143

Dosage Form

Solution for Injection for IV use

Issuance Date

August 5, 2022

Expiry Date

November 2, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength5 mg/mL
Packaging10 mL USP Type I colorless glass vial Box of 1's and 10's and 20 mL USP Type I colorless glass vial Box of 1's and 10's

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antineoplastic
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

OXALIPLATINActive
Monograph: Oxaliplatin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform